Indian equity markets are likely to open in the red amid, hinted SGX Nifty. Nifty futures traded 49.5 pts, or 0.28% lower at 17,440.50 on the Singapore Exchange, signalling that Dalal Street was headed for a negative start. In the previous session, BSE Sensex tanked 872 points or 1.46%, to end below the 59,000, while …
MSD (known as Merck in U.S. and Canada) recently announced that the Drug Controller General of India (DCGI) has approved KEYTRUDA (pembrolizumab), MSD’s anti-PD-1 therapy, for the treatment of triple-negative breast cancer and renal cell carcinoma in adults. KEYTRUDA has been approved for high-risk early-stage and metastatic triple-negative breast cancer for select patients who are …